Dr. Rui George Dasilva Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 540 Canal St, King City, CA 93930 Phone: 831-385-0886 |
Mrs. Glenda Peterson Allred, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 425 Broadway St, King City, CA 93930 Phone: 831-385-3259 Fax: 831-385-3928 |
Thuan Vo Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 540 Canal St, King City, CA 93930 Phone: 831-385-0886 |
Ryan Rana, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 620 Broadway St Ste P, King City, CA 93930 Phone: 831-204-6020 |
Tawfiq Imam, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 540 Canal St,, Rite Aid Pharmacy #5880, King City, CA 93930 Phone: 831-385-0886 |
Carl Jorgensen Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Riteaid, 540 Canal Street, King City, CA 93930 Phone: 831-385-0886 |
Vijay Diesh Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 Canal St, King City, CA 93930 Phone: 831-385-7208 |
Miss Marie Samir Girguis, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 540 Canal St, King City, CA 93930 Phone: 831-385-0866 |
News Archive
The Congressional Budget Office announcement May 11, 2010, that the Patient Protection and Affordable Care Act (Obamacare) would cost, over the next ten years, $115 Billion more, brings the total cost over $1 Trillion. Imagine—Congress and the President spent a whole year jamming a 2,309 page monster down our throats on the pretense of "eliminating fraud, waste and abuse (in the delivery of medical care) at a lower cost". This same Congressional Budget Office, using the contrived numbers given by Congress, had previously said Obamacare would REDUCE federal deficits by $143 Billion. I smell FRAUD.
When a bedridden patient needs to be lifted or turned or an unruly visitor needs to be escorted off the premises, the best man for the job at UCLA Medical Center, Santa Monica might actually be a woman
Boston Scientific Corporation announces that the U.S. District Court for the District of New Jersey has found all the asserted patents in a suit brought by Johnson & Johnson to be invalid and entered judgment in favor of Boston Scientific.
In the presentation, Damian Marron will provide an overview of TxCell and its personalized T cell immunotherapy platform ASTrIA. Additional details will also be provided to institutional investors in one on one meetings at the conference.
› Verified 1 days ago